HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1-Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring Study | Zendy

Somnuek Sungkanuparph | Zendy; Rebecca Oyomopito | Zendy; Sunee Sirivichayakul | Zendy; Thira Sirisanthana | Zendy; P C K Li | Zendy; Pacharee Kantipong | Zendy; CKC Lee | Zendy; Adeeba Kamarulzaman | Zendy; Liesl Messerschmidt | Zendy; Matthew Law | Zendy; Praphan Phanuphak | Zendy

Open Access

HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1-Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring Study

Author(s) -

Somnuek Sungkanuparph,

Rebecca Oyomopito,

Sunee Sirivichayakul,

Thira Sirisanthana,

P C K Li,

Pacharee Kantipong,

CKC Lee,

Adeeba Kamarulzaman,

Liesl Messerschmidt,

Matthew Law,

Praphan Phanuphak

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir107

Subject(s) - medicine , drug resistance , antiretroviral therapy , human immunodeficiency virus (hiv) , hiv drug resistance , virology , antiretroviral drug , drug , sida , viral disease , viral load , pharmacology , biology , microbiology and biotechnology

Of 682 antiretroviral-naïve patients initiating antiretroviral therapy in a prospective, multicenter human immunodeficiency virus type 1 (HIV-1) drug resistance monitoring study involving 8 sites in Hong Kong, Malaysia, and Thailand, the prevalence of patients with ≥1 drug resistance mutation was 13.8%. Primary HIV drug resistance is emerging after rapid scaling-up of antiretroviral therapy use in Asia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research